The 11 analysts offering 1 year price forecasts for 0RA9 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 11 analysts giving stock ratings to 0RA9 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0RA9 EPS for the last quarter is −1.30 EUR despite the estimation of −1.37 EUR. In the next quarter EPS is expected to reach −1.48 EUR. Track more of ABIVAX EUR0.01 financials and stay on top of what is up with the company.
In the next quarter ABIVAX EUR0.01 revenue is expected to reach 2.95 M EUR. Check out ABIVAX EUR0.01 revenue and earnings and make informed decisions.
According to analysts, 0RA9 price target is 29.54 EUR with a max estimate of 47.13 EUR and a min estimate of 14.49 EUR. Check if this forecast comes true in a year, meanwhile watch ABIVAX EUR0.01 stock price chart and keep track of the current situation with 0RA9 news and stock market news.
We've gathered opinions of 11 analysts rating 0RA9 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.